Detalla, Baby Girl .
HRN: 27-01-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/28/2025
05/05/2025
IV
10mg As LD Then 5mg
Q48H
Candida Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes